Author: Leslie Gibson McCarthy

The inauguration of Andrew D. Martin as the 15th chancellor of Washington University Oct. 3 will begin with a faculty symposium that explores connections between research and discovery as well as connections to the St. Louis community at large.

Scientists at the School of Medicine have pinpointed the precise cause of Krabbe disease, a neurodegenerative condition that usually causes death by age 3.

A single high dose of radiation aimed at the heart significantly reduces episodes of a potentially deadly rapid heart rhythm, according to results of a phase one/two study at the School of Medicine.

The School of Medicine has received a $5 million grant from the Edward P. Evans Foundation to establish and endow a new center focused on advancing research and improving treatments for a rare set of blood disorders called myelodysplastic syndromes, or MDS, that leaves the body unable to make enough healthy blood cells.

As part of a federal initiative to end the HIV epidemic, Washington University in St. Louis will establish a center to provide guidance and support to local organizations working to reduce HIV infection rates in their communities. Among other things, the center will help organizations provide PrEP, a medicine that prevents HIV infection.

Nearly all babies born prematurely receive antibiotics. A new study from the School of Medicine suggests that such early antibiotic treatment could have long-lasting and potentially harmful effects on the gut microbiome.

The inauguration of Andrew D. Martin as the 15th chancellor of Washington University in St. Louis will take place Oct. 3 in a daylong, communitywide celebration.

The Washington University in St. Louis community — students, faculty, staff, alumni and friends — is invited to become a part of the Oct. 3 inauguration of Andrew D. Martin by submitting group photos and greetings. Here’s how to participate.

A test for signs of Zika infection has been granted market authorization by the Food and Drug Administration. The test is based in part on an antibody developed by researchers at the School of Medicine.

Researchers at the School of Medicine have developed a way to fluorescently tag cells infected with chikungunya virus. The technique opens up new avenues to study how the virus persists in the body and potentially could lead to a treatment.